Titration methods for rVSV-based vaccine manufacturing-Reference-Cited by-同舟云学术

Titration methods for rVSV-based vaccine manufacturing

Published:2020 Issue: Volume:7 Page:100806
ISSN:2215-0161
Container-title:MethodsX
language:en
Short-container-title:MethodsX

Author:

Gélinas Jean-François^ORCID,Kiesslich Sascha,Gilbert Rénald,Kamen Amine A.^ORCID

Funder

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Medical Laboratory Technology,Clinical Biochemistry

Reference31 articles.

1. Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses;Garbutt;J. Virol.,2004

2. Rhabdoviruses as vaccine platforms for infectious disease and cancer;Zemp;Biotechnol. Genet. Eng. Rev.,2018

3. First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response;Press Announc,2019

4. Ebola is now “preventable and treatable,” says WHO after approving vaccine in record time;Mahase;BMJ,2019

5. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses;Jones;Nat. Med.,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development;Molecular Therapy - Methods & Clinical Development;2024-06

2. The Utilization and Development of Viral Vectors in Vaccines as a Prophylactic Treatment Against Ebola Virus as an Emerging and Zoonotic Infectious Disease;Mini-Reviews in Medicinal Chemistry;2024-02

3. Viral genomics;Microbial Genomics: Clinical, Pharmaceutical, and Industrial Applications;2024

4. Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine;Vaccines;2023-04-14

5. Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate;Vaccine;2023-03